Piroxicam betadex

Drug Profile

Piroxicam betadex

Alternative Names: Beta-cyclodextrin piroxicam; Brexecam; Brexidol; Brexin; Brexine; Brexinil; CHF 1194; Cicladol; Cycladol; Flogene; Piroxicam beta-cyclodextrin; Piroxicam beta-cyclodextrin complex; Solocalm Rapido

Latest Information Update: 16 Mar 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi
  • Class Antirheumatics; Beta-Cyclodextrins; Carbohydrates; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Ankylosing spondylitis; Dysmenorrhoea; Gout; Inflammation; Musculoskeletal disorders; Osteoarthritis; Pain; Rheumatic disorders; Rheumatoid arthritis
  • No development reported Migraine; Tension type headache

Most Recent Events

  • 16 Apr 2004 Amersham has merged with GE Medical Systems to form GE Healthcare
  • 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
  • 23 Aug 2001 Schwarz Pharma has terminated its licensing agreement for the agent in the USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top